Stay updated with breaking news from Program Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEEDHAM, Mass., Aug. 10, 2023 -- Candel Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing viral immunotherapies to help patients fight cancer, today reported... -Today at 08:02 am- MarketScreener
CRB-701 Phase 1 trial in China is ahead of schedule with dose escalation completion expected Q4 2023 and U.S. clinical trial start planned for Q1 ...
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...
NDA submitted to US FDA for ensifentrine for maintenance treatment of COPD Phase 3 ENHANCE data published in the American Journal of Respiratory and Critical Care Medicine Strong balance sheet to...
-- Management to Host Conference Call at 4:30 p.m. ET Today -- ...